DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 6, 2026
4 Jan 6, 2026
8-K Jan 5, 2026 FORM 8-K
8-K Dec 18, 2025 FORM 8-K
4 Dec 8, 2025 OWNERSHIP DOCUMENT
4 Nov 25, 2025
S-8 Nov 13, 2025 FORM S-8
10-Q Nov 12, 2025 FORM 10-Q
8-K Nov 12, 2025 FORM 8-K
SCHEDULE 13G/A Nov 7, 2025
4 Nov 3, 2025
3 Nov 3, 2025
SCHEDULE 13G/A Oct 15, 2025
4 Sep 4, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13G/A Sep 4, 2025
SCHEDULE 13G Aug 27, 2025
EFFECT Aug 22, 2025
424B2 Aug 22, 2025 FORM 424B2
CORRESP Aug 20, 2025
UPLOAD Aug 18, 2025
8-K Aug 12, 2025 FORM 8-K
S-3 Aug 12, 2025 FORM S-3
10-Q Aug 12, 2025 FORM 10-Q
8-K Aug 12, 2025 FORM 8-K
EFFECT Aug 8, 2025
← Newer Page 2 of 18 · 427 filings Older →